Kansas Sci-Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Kansas Sci-Tech Reporter.

Press releases published on May 4, 2026

2 hours ago

Abeona Therapeutics® Announces Date of First Quarter Financial Results

Indeterminate GlobeNewswire

2 hours ago

Satellogic Expands Global Sales Force with Senior Defense and Intelligence Industry Veterans

Indeterminate GlobeNewswire

2 hours ago

FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial

Indeterminate GlobeNewswire

2 hours ago

Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

Indeterminate GlobeNewswire

2 hours ago

Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion

Indeterminate GlobeNewswire

2 hours ago

Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026

Indeterminate GlobeNewswire

2 hours ago

NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress

Indeterminate GlobeNewswire

2 hours ago

Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6

Indeterminate GlobeNewswire

2 hours ago

Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026

Indeterminate GlobeNewswire

2 hours ago

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

Indeterminate GlobeNewswire

2 hours ago

Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial

Indeterminate GlobeNewswire

2 hours ago

CPTx to present preclinical proof-of-principle of its DNA-based in vivo CAR T platform at ASGCT Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026

Indeterminate GlobeNewswire

2 hours ago

Recludix Pharma Announces Upcoming Oral Presentations on Preclinical Data for Oral STAT6 Inhibitor REX-8756 and Topical STAT 1/3 Inhibitors at the Society for Investigative Dermatology (SID) Annual Meeting

Indeterminate GlobeNewswire

2 hours ago

Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society

Indeterminate GlobeNewswire

2 hours ago

Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1

Indeterminate GlobeNewswire

2 hours ago

Zoom Recognizes the Rise of AI-Powered Businesses of One with Inaugural Solopreneur 50

Indeterminate GlobeNewswire

2 hours ago

Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer

Indeterminate GlobeNewswire

2 hours ago

4DMT to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire